411 related articles for article (PubMed ID: 25355422)
1. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
[TBL] [Abstract][Full Text] [Related]
2. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.
da Silva Xavier G; Mondragon A; Sun G; Chen L; McGinty JA; French PM; Rutter GA
Diabetologia; 2012 Oct; 55(10):2667-2676. PubMed ID: 22717537
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice.
Nguyen-Tu MS; Martinez-Sanchez A; Leclerc I; Rutter GA; da Silva Xavier G
Diabetologia; 2021 Jan; 64(1):129-141. PubMed ID: 33068125
[TBL] [Abstract][Full Text] [Related]
4. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.
Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K
Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626
[TBL] [Abstract][Full Text] [Related]
5. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.
da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA
Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277
[TBL] [Abstract][Full Text] [Related]
7. Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β-cell are associated with glucose intolerance in humans and mice.
Mehta ZB; Fine N; Pullen TJ; Cane MC; Hu M; Chabosseau P; Meur G; Velayos-Baeza A; Monaco AP; Marselli L; Marchetti P; Rutter GA
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E488-507. PubMed ID: 27329800
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor-7-like 2 (
Nguyen-Tu MS; da Silva Xavier G; Leclerc I; Rutter GA
J Biol Chem; 2018 Sep; 293(36):14178-14189. PubMed ID: 29967064
[TBL] [Abstract][Full Text] [Related]
9. The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells.
Shao W; Szeto V; Song Z; Tian L; Feng ZP; Nostro MC; Jin T
J Mol Endocrinol; 2018 Jul; 61(1):1-12. PubMed ID: 29678908
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.
Le Bacquer O; Kerr-Conte J; Gargani S; Delalleau N; Huyvaert M; Gmyr V; Froguel P; Neve B; Pattou F
Diabetologia; 2012 Oct; 55(10):2677-2681. PubMed ID: 22911383
[TBL] [Abstract][Full Text] [Related]
12. Tcf7l2 plays pleiotropic roles in the control of glucose homeostasis, pancreas morphology, vascularization and regeneration.
Facchinello N; Tarifeño-Saldivia E; Grisan E; Schiavone M; Peron M; Mongera A; Ek O; Schmitner N; Meyer D; Peers B; Tiso N; Argenton F
Sci Rep; 2017 Aug; 7(1):9605. PubMed ID: 28851992
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner.
Sakhneny L; Rachi E; Epshtein A; Guez HC; Wald-Altman S; Lisnyansky M; Khalifa-Malka L; Hazan A; Baer D; Priel A; Weil M; Landsman L
Diabetes; 2018 Mar; 67(3):437-447. PubMed ID: 29246974
[TBL] [Abstract][Full Text] [Related]
14. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs.
Smith EP; An Z; Wagner C; Lewis AG; Cohen EB; Li B; Mahbod P; Sandoval D; Perez-Tilve D; Tamarina N; Philipson LH; Stoffers DA; Seeley RJ; D'Alessio DA
Cell Metab; 2014 Jun; 19(6):1050-7. PubMed ID: 24836562
[TBL] [Abstract][Full Text] [Related]
15. A Critical Role for β-Catenin in Modulating Levels of Insulin Secretion from β-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization.
Sorrenson B; Cognard E; Lee KL; Dissanayake WC; Fu Y; Han W; Hughes WE; Shepherd PR
J Biol Chem; 2016 Dec; 291(50):25888-25900. PubMed ID: 27777306
[TBL] [Abstract][Full Text] [Related]
16. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
Loder MK; da Silva Xavier G; McDonald A; Rutter GA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
[TBL] [Abstract][Full Text] [Related]
17. β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice.
Ravier MA; Leduc M; Richard J; Linck N; Varrault A; Pirot N; Roussel MM; Bockaert J; Dalle S; Bertrand G
Diabetologia; 2014 Mar; 57(3):532-41. PubMed ID: 24317793
[TBL] [Abstract][Full Text] [Related]
18. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
